Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody

S Knox, RT Hoppe, D Maloney, I Gibbs, S Fowler, C Marquez, PJ Cornbleet, R Levy

Blood (1996) 87 (3): 893–899.

https://doi.org/10.1182/blood.V87.3.893.bloodjournal873893

Published: 1996

Journal Articles

Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge [editorial]

RT Hoppe

Blood (1991) 77 (10): 2093–2095.

https://doi.org/10.1182/blood.V77.10.2093.2093

Published: 1991

Journal Articles

Clonal rearrangement of the T cell receptor beta gene in the circulating lymphocytes of erythrodermic follicular mucinosis

PE LeBoit, EA Abel, ML Cleary, RT Hoppe, ML Williams, GS Wood, TG Parslow

Blood (1988) 71 (5): 1329–1333.

https://doi.org/10.1182/blood.V71.5.1329.1329

Published: 1988

Journal Articles

Stage I-II Hodgkin's disease: current therapeutic options and recommendations

RT Hoppe

Blood (1983) 62 (1): 32–36.

https://doi.org/10.1182/blood.V62.1.32.32

Published: 1983

Journal Articles

Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia

GS Wood, DG Deneau, RA Miller, R Levy, RT Hoppe, RA Warnke

Blood (1982) 59 (5): 876–882.

https://doi.org/10.1182/blood.V59.5.876.876

Published: 1982

Journal Articles

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

RT Hoppe, CN Coleman, RS Cox, SA Rosenberg, HS Kaplan

Blood (1982) 59 (3): 455–465.

https://doi.org/10.1182/blood.V59.3.455.455

Published: 1982

Journal Articles

The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

RT Hoppe, P Kushlan, HS Kaplan, SA Rosenberg, BW Brown

Blood (1981) 58 (3): 592–598.

https://doi.org/10.1182/blood.V58.3.592.592

Published: 1981

NARROW

Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody

Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge [editorial]

Clonal rearrangement of the T cell receptor beta gene in the circulating lymphocytes of erythrodermic follicular mucinosis

Stage I-II Hodgkin's disease: current therapeutic options and recommendations

Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

Email alerts

ASH Publications

American Society of Hematology

Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody

Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge [editorial]

Clonal rearrangement of the T cell receptor beta gene in the circulating lymphocytes of erythrodermic follicular mucinosis

Stage I-II Hodgkin's disease: current therapeutic options and recommendations

Subtypes of cutaneous T-cell lymphoma defined by expression of leu-1 and Ia

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience

The treatment of advanced stage favorable histology non-Hodgkin's lymphoma: a preliminary report of a randomized trial comparing single agent chemotherapy, combination chemotherapy, and whole body irradiation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only